Erlotinib versus etoposide/cisplatin with radiation therapy in unresectable stage III epidermal growth factor receptor mutation-positive non-small cell lung cancer: a …

L Xing, G Wu, L Wang, J Li, J Wang, Z Yuan… - International Journal of …, 2021 - Elsevier
Purpose This study aimed to compare erlotinib (E) and etoposide/cisplatin (EP) with
concurrent radiation therapy (RT) for patients with stage IIIA/B unresectable advanced non …
被引用次数：40 相关文章

Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung …

L Xing, G Wu, L Wang, J Li, J Wang - International Journal of Radiation …, 2021 - inis.iaea.org
Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy i..|INIS IAEA NUCLEUS Sign In
Sign In Register Help 50+ years of INIS International Nuclear Information System International …

[引用][C] Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell …

L Xing, G Wu, L Wang, J Li, J Wang, Z Yuan… - International Journal of …, 2021 - cir.nii.ac.jp
Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal
Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter …

Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung …

L Xing, G Wu, L Wang, J Li, J Wang, Z Yuan… - … Journal of Radiation …, 2020 - europepmc.org
Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III
Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A …

Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung …

L Xing, G Wu, L Wang, J Li, J Wang, Z Yuan… - International Journal of …, 2021 - redjournal.org
Purpose This study aimed to compare erlotinib (E) and etoposide/cisplatin (EP) with
concurrent radiation therapy (RT) for patients with stage IIIA/B unresectable advanced non …

Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung …

L Xing, G Wu, L Wang, J Li, J Wang… - … journal of radiation …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose This study aimed to compare erlotinib (E) and etoposide/cisplatin (EP) with
concurrent radiation therapy (RT) for patients with stage IIIA/B unresectable advanced non …